Workflow
Annexon, Inc. (ANNX) Falls More Steeply Than Broader Market: What Investors Need to Know
AnnexonAnnexon(US:ANNX) Zacks Investment Research·2024-04-10 23:21

Company Summary - Annexon, Inc. (ANNX) closed at $6.17, reflecting a -0.96% change from the previous day's closing price, underperforming the S&P 500 which fell by 0.95% [1] - The stock has increased by 35.73% over the past month, outperforming the Medical sector's decline of 3.76% and the S&P 500's gain of 1.78% [1] - The upcoming earnings report is expected to show an EPS of -$0.32, representing a 38.46% increase compared to the same quarter last year [1] - Recent analyst forecast revisions for Annexon, Inc. are crucial as they indicate short-term business trends, with positive changes reflecting optimism about the company's profitability [1] Industry Summary - The Medical - Biomedical and Genetics industry is part of the broader Medical sector and currently holds a Zacks Industry Rank of 80, placing it in the top 32% of over 250 industries [2] - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has shown that stocks rated 1 have delivered an average annual return of +25% since 1988 [2] - The top 50% rated industries outperform the bottom half by a factor of 2 to 1, indicating the importance of industry ranking in stock performance [3]